Pathologic Complete Response to Neoadjuvant Therapy in Patients with Pancreatic Ductal Adenocarcinoma Is Associated with Better Prognosis

In patients with pancreatic ductal adenocarcinoma (PDA) who received neoadjuvant therapy and pancreatectomy, pathologic complete response (pCR) is rarely observed and the prognostic significance of pCR is not clear. In this study, we reported 11 patients with pCR (2.5%) from 442 patients with PDA wh...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Zhao, Qing, Rashid, Asif, Gong, Yun, Katz, Matthew H., Lee, Jeffrey E., Wolf, Robert, Balachandran, Aparna, Varadhachary, Gauri R., Pisters, Peter W, Wang, Hua, Gomez, Henry F., Abbruzzese, James L., Fleming, Jason B., Wang, Huamin
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3832988/
https://ncbi.nlm.nih.gov/pubmed/22050964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.anndiagpath.2011.08.005
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi